在心脏病试验中导航介质干细胞剂量和输送途径:全面概述
Mohammad Reza Khalili1, Salma Ahmadloo2, Seyed Amin Mousavi3
1Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.
Regenerative therapy
|March 31, 2025
概括
使用介质干细胞 (MSC) 治疗心脏病的临床试验缺乏标准化的方案. 本次审查强调了各种方法和数量,强调了在心脏再生研究中对MSCs的普遍指导方针的需要.
科学领域:
- 再生医学是一种再生医学.
- 心脏病学 心脏病学
- 干细胞疗法是一种干细胞疗法.
背景情况:
- 介质细胞干细胞 (MSCs) 显示出治疗心脏病的前景.
- 许多临床试验已经研究了基于MSC的心脏治疗.
- 缺乏MSC管理协议的标准化.
研究的目的:
- 审查自2009年以来使用MSC治疗心脏病的临床试验.
- 为了识别MSC移植方法和剂量的变化.
- 要突出在心脏试验中MSC应用的普遍指导方针的缺乏.
主要方法:
- 对涉及心脏病MSC的临床试验进行系统审查.
- 对试验数据的分析,重点是注射途径,剂量和频率.
- 识别MSC利用中的趋势和不一致性.
主要成果:
- 在试验中观察到各种各样的移植方法.
- 在不同的研究中,使用了不同数量的MSC.
- 在心脏试验中没有确定MSC剂量或给药的通用指南.
结论:
- 在MSC应用中的异质性对心脏再生的安全性和有效性提出了挑战.
- 建立标准化的协议对于推进基于MSC的心脏病治疗至关重要.
- 需要进一步的研究来确定心血管疾病的最佳MSC治疗策略.
相关概念视频
01:19Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
01:21Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K